Position in BLLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$40,837,710
+$18,486,640 QoQ
Shares Held
340,371
+20.2% QoQ
Ownership
0.721%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,851,050,368 across 35 Diagnostics & Research names. BLLN ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,503,527 | $4,263,328,287 | |
| 2 | NTRA |
Natera, Inc.
|
12,865,346 | $3,492,298,164 | |
| 3 | DHR |
Danaher Corp /De/
|
12,185,400 | $2,321,074,982 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
6,139,775 | $1,186,327,314 | |
| 5 | WAT |
Waters Corp /De/
|
2,158,391 | $809,482,952 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,520,438 | $746,156,824 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
755,791 | $397,878,607 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,268,384 | $355,147,520 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,837,710 | 340,371 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $22,351,070 | 283,140 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $32,077,841 | 391,958 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||